Those shares will trade on the Nasdaq under the stock symbol ... myeloid leukemia (CML). This drug is a small molecule inhibitor of tyrosine kinases, enzymes that drive cancer growth.

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is ...

Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily ... B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...

As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionally. However, the Company can give no assurance that the ADS trading price after the ADS Ratio Change will ...

In Japan, the crane is considered a mythical animal that lives for 1,000 years; because of this, it became a symbol of good luck and ... to have caused her to develop leukemia as she got older.

He is an associate professor of clinical medicine at Weill Cornell Medical College. Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow. It affects cells that ...